A possible alternative is to modify the dimerizable partners fused to the Cre moieties themselves and use a mutated FKBP12 only, such as the F36V mutant, in conjunction with homodimerizer drugs that do not interfere with endogenous FKBP12 but have good pharmacokinetic characteristics [47] [49].
Matsuzaki et al. [ 19] demonstrated that a tyrosine-sulphated form of CLEL8 (restoredstoRAM RAmaintenancece of a tyrosine sulphotransferase mutant in conjunction with PSK and PSY1.
It was recently shown that col- 26 in N. crassa also functions in nutrient signaling and that a Δ col- 26 mutant, in conjunction with a deletion of the carbon catabolite repressor, cre- 1, suppresses the inability of a Δ vib- 1 (a NDT80-like transcription factor) mutant to utilize cellulose [ 27].
The reported increases in SA levels and the gamut of phytohormone responsive genes and redox transmitters that are altered in the Atnudt7-1 mutant in conjunction with the observed changes in NAD+, NADH, GSH and ascorbate, suggests novel interconnections between redox signaling, antioxidative systems and phytohormone-mediated oxidative cell death pathways [ 31] (Fig. 10).
We have isolated two additional RL6058 Lr34 mutants and, in conjunction with the six previously identified mutants, undertaken a detailed characterisation of their response to stripe rust and stem rust infection under field conditions and in response to leaf rust at the seedling stage when grown under controlled conditions.
CaZF partially suppresses salt-hypersensitive phenotypes of hog1, can and hog1can mutants and in conjunction, stimulates HOG and CAN pathway genes with subsequent accumulation of glycerol in absence of Hog1p and CAN.
Based on the structures of wt-KaiC and six mutants and in conjunction with data from site-specific mutations (Fig. 3), the divergent functions of the CI and CII halves in the control of the KaiABC oscillator and the roles of individual residues underlying the mechanisms of the kinase (CII half) and ATPase (CI and CII halves) activities can be revisited.
Previously we engineered a N346A/C348A mutant of PylRS (PylRS N346A/C348A)) and demonstrated that this mutant enzyme in conjunction with tRNA CUA Pyl was able to incorporate a wide range of tyrosine and phenylalanine derivatives into proteins in response to the amber codon in E. coli.
The creation of a R349P desmin knock-in mouse model expressing untagged mutant desmin in conjunction with the generation of a R349P mutant-specific antibody allowed us to analyze these central issues in relation to the clinical, hemodynamic, morphological, and biomechanical aspects of desminopathies.
